| Model Number |
EVPROPLUS-29US |
| Medical Device Problem Codes |
Perivalvular Leak (1457); Insufficient Device Problem Information (3190); Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Codes |
Dyspnea (1816); Heart Failure/Congestive Heart Failure (4446); Valvular Insufficiency/ Regurgitation (4449); Swelling/ Edema (4577); Insufficient Information (4580)
|
| Date of Event |
04/03/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that approximately 6 years following the implant of a transcatheter aortic valve, the valve failed due to an unspecified cause.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated data: a4, b1, b2, b5, h1, h6, additional codes.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information was received that there was aortic regurgitation with the valve.Moderate to severe paravalvular leak (pvl) was reported.The patient was recently hospitalized for acute congestive heart failure (chf) with symptoms of shortness of breath (sob) and leg swelling.There was no treatment planned.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated data: additional codes medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|